Evidence map›Paper›PMID 42897657›Full record

ReviewJournal of translational medicine2026

Alveolar organoids: from model systems to applications in respiratory diseases.

Yuanfang Xing, Luyu Yang, Zhimin Cao, Dongchang Wang, Huan Ye

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yuanfang Xing *Beijing Tuberculosis and Thoracic Tumor Research Institute, Courtyard 1, No.9 Beiguan Street, Tongzhou District, Beijing, 101199, China.
Luyu Yang *Beijing Tuberculosis and Thoracic Tumor Research Institute, Courtyard 1, No.9 Beiguan Street, Tongzhou District, Beijing, 101199, China.
Zhimin Cao *Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Peking University, Beijing, 100191, China.
Dongchang Wang *Beijing Tuberculosis and Thoracic Tumor Research Institute, Courtyard 1, No.9 Beiguan Street, Tongzhou District, Beijing, 101199, China. wangdongchang@bjxkyy.cn.
Huan Ye *Beijing Tuberculosis and Thoracic Tumor Research Institute, Courtyard 1, No.9 Beiguan Street, Tongzhou District, Beijing, 101199, China. yedahuan@yeah.net.

Funding

Innovative Research Group Project of the National Natural Science Foundation of China 82370087Natural Science Foundation of Beijing Municipality L234007
6 · The paper itself

Abstract

Organoid technology has emerged as a research hotspot in the biomedical field in recent years, providing important methodologies for disease modeling, drug screening, and regenerative medicine. Alveolar organoids serve as crucial models for studying respiratory diseases, and their technological evolution and application expansion reflect key advances in this field. This article systematically reviews the developmental history of organoids, provides an in-depth comparison of the applicability and limitations of different culture and characterization strategies for alveolar organoids, summarizes and critically analyzes alveolar organoid models established for common respiratory diseases, and offers perspectives on future directions in this area.

Indexed as

Models, BiologicalOrganoidsPulmonary AlveoliRespiratory Tract DiseasesAnimalsHumansAlveolar organoidOrganoidRespiratory diseaseThree-dimensional culture

Identifiers

PMID42897657
PMCPMC13681799

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.